Basics |
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance Inc is a pharmacy led health and wellbeing company. It operates retail pharmacy store chain in the United States. The firm sells and markets its products under brands such as Walgreens, Duane Reade, Boots and Alliance Healthcare.
|
IPO Date: |
December 31, 2014 |
Sector: |
Consumer Staples |
Industry: |
Food and Staples Retailing |
Market Cap: |
$9.69B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.59 | 1.24%
|
Avg Daily Range (30 D): |
$0.05 | 0.47%
|
Avg Daily Range (90 D): |
$0.15 | 1.36%
|
Institutional Daily Volume |
Avg Daily Volume: |
6.87M |
Avg Daily Volume (30 D): |
8.06M |
Avg Daily Volume (90 D): |
15.79M |
Trade Size |
Avg Trade Size (Sh.): |
135 |
Avg Trade Size (Sh.) (30 D): |
258 |
Avg Trade Size (Sh.) (90 D): |
262 |
Institutional Trades |
Total Inst.Trades: |
33,513 |
Avg Inst. Trade: |
$5.46M |
Avg Inst. Trade (30 D): |
$3.6M |
Avg Inst. Trade (90 D): |
$3.75M |
Avg Inst. Trade Volume: |
.13M |
Avg Inst. Trades (Per Day): |
12 |
Market Closing Trades |
Avg Closing Trade: |
$35.84M |
Avg Closing Trade (30 D): |
$20.93M |
Avg Closing Trade (90 D): |
$24.07M |
Avg Closing Volume: |
888.79K |
|
|
|
|
News |
May 8, 2025 @ 7:15 AM
Want $1,000 in Annual Dividends? Invest $18,000 in...
Source: Jennifer Saibil
|
Mar 26, 2025 @ 12:00 PM
INVESTOR ALERT: Pomerantz Law Firm Announces the F...
Source: Pomerantz Llp
|
Mar 22, 2025 @ 5:49 PM
WBA FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Enc...
Source: N/A
|
Mar 20, 2025 @ 5:01 PM
Investors in Walgreens Boots Alliance, Inc. Should...
Source: The Gross Law Firm
|
Mar 16, 2025 @ 9:28 PM
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Enc...
Source: N/A
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-6.69
|
$-3.3
|
$-.31
|
Diluted EPS
|
$-6.69
|
$-3.3
|
$-.31
|
Revenue
|
$ 151.95B
|
$ 38.59B
|
$ 39.46B
|
Gross Profit
|
$ 26.43B
|
$ 6.94B
|
$ 6.78B
|
Net Income / Loss
|
$ -7488M
|
$ -4035M
|
$ -605M
|
Operating Income / Loss
|
$ -6678M
|
$ -5567M
|
$ -245M
|
Cost of Revenue
|
$ 125.52B
|
$ 31.65B
|
$ 32.68B
|
Net Cash Flow
|
$ 525M
|
$ -69M
|
$ -1909M
|
PE Ratio
|
|
|
|
|